Centene Corporation (NYSE:CNC) has experienced a decline in the consensus price target over the past year, from $83.67 to $69.
The company reported a diluted EPS of $2.63 and an adjusted diluted EPS of $2.90 in the first quarter of 2025, indicating a 28% increase from the previous year.
Morgan Stanley has set an optimistic price target of $112 for Centene, reflecting confidence in its continued growth and performance.
Centene Corporation (NYSE:CNC) is a leading healthcare enterprise in the United States, focusing on providing services to under-insured and uninsured individuals. The company operates through two main segments: Managed Care and Specialty Services, offering a wide range of healthcare products and services. Centene’s competitors include other major healthcare providers like UnitedHealth Group and Anthem.
Over the past year, the consensus price target for Centene’s stock has seen a decline. A year ago, the average price target was $83.67, but it has decreased to $69 in the last quarter and last month. This downward trend in analysts’ expectations could be due to various factors, including changes in the healthcare industry, company performance, or broader market conditions.
Despite the decline in the consensus price target, Centene has reported strong financial performance in its first quarter of 2025. The company achieved a diluted earnings per share (EPS) of $2.63, with an adjusted diluted EPS of $2.90, marking a 28% increase compared to the first quarter of 2024. Additionally, Centene experienced a 17% year-over-year growth in premium and service revenue.
Morgan Stanley has set a price target of $112 for Centene’s stock, reflecting confidence in the company’s continued growth and performance. This optimistic outlook is supported by Centene’s strong track record of surpassing earnings expectations and its potential to exceed estimates in upcoming reports. The company’s stock also saw a 5.9% increase during the last trading session, suggesting potential continued strength.
Investors and analysts are closely watching Centene’s performance, expecting it to meet or exceed market expectations. Staying updated with the latest company news, earnings reports, and changes in the healthcare policy landscape could provide further insights into the stock’s future performance and help investors make informed decisions.
